NCT06491576View on ClinicalTrials.gov

A Clinical Trial of BGT-002 Tablets in Subjects With Nonalcoholic Steatohepatitis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

March 21, 2023

Primary Completion Date

March 4, 2024

Study Completion Date

March 4, 2024

Conditions
NASH
Interventions
DRUG

BGT-002

taking the study drug orally

DRUG

Placebo

taking the placebo orally

Trial Locations (1)

130031

The First Bethune Hospital of Jilin University, Changchun

Sponsors
All Listed Sponsors
lead

Burgeon Therapeutics Co., Ltd.

INDUSTRY

NCT06491576 - A Clinical Trial of BGT-002 Tablets in Subjects With Nonalcoholic Steatohepatitis | Biotech Hunter | Biotech Hunter